Loading…
Loading…
ELLXF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ELLXF and 80,000+ other tickers.
See exactly how ELLXF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ELLXF and 80,000+ other tickers.
Elixinol Wellness Limited, an Australian-based company established in 2017 with its headquarters in Sydney, operates as a global producer and supplier of hemp-derived products. The firm crafts and distributes a diverse range of hemp-based wellness, beauty, and food items, marketed under its well-known Elixinol and Hemp Foods Australia brands. Its comprehensive product portfolio encompasses cannabidiol (CBD) products, dietary supplements, various food items, topicals, and skincare solutions. These offerings reach consumers across significant international markets, including the Americas…
Elixinol Wellness Limited (ELLXF) Shareholder/Analyst Call Prepared Remarks Transcript
Elixinol Wellness Limited (ELLXF) Discusses New National Distribution Agreement and Capital Structure Reset Transcript
Elixinol Wellness Limited (ELLXF) Q4 2025 Earnings Call Transcript
Elixinol Wellness Limited (OTCMKTS:ELLXF - Get Free Report) was the recipient of a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling 46 shares, a decrease of 43.2% from the November 30th total of 81 shares. Based on an average daily volume of 2,792 shares,
SYDNEY , Feb. 2, 2024 /PRNewswire/ -- Elixinol Wellness Limited (ASX: EXL) continues to be a pioneer in the global hemp industry, with the release of a new paper into the safety of Elixinol Hemp Extract in leading scientific publication, Journal of Toxicology. The paper, entitled "Safety of Elixinol Hemp Extract: In VitroGenetic Toxicity and Subchronic Toxicity in Rat", reports on safety studies of Elixinol Hemp Extract in rats and concludes that the Extract is safe to use and does not have any adverse effects at the highest dose tested.